InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Bleil Lynn Dorsey. Officer active across 1 companies, notably Amicus Therapeutics, INC.. Cumulatively, 5 reports have been logged. Total volume traded: €408k. The latest transaction was disclosed on 9 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
012,671 shares0
Common Stock
SEC:0001209191-22-035821:0·
010,115 shares0
Common Stock
SEC:0001209191-21-040390·
010,115 shares0
Common Stock
SEC:0001209191-21-040390:0·
€204,10328,605 shares@ €7.13520.0045% mcap100.0% of flow
Common Stock
SEC:0001209191-21-036239·
Ideal exit: 19 Feb 2022 (T+270)
€204,10328,605 shares@ €7.13520.0045% mcap50.0% of flow
Common Stock
SEC:0001209191-21-036239:0·
Ideal exit: 19 Feb 2022 (T+270)
5 of 5 declarations
About Bleil Lynn Dorsey
Lynn Dorsey Bleil is a director at Amicus Therapeutics, INC.
